Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q138795> ?p ?o }
Showing triples 1 to 44 of
44
with 100 triples per page.
- Q138795 subject Q6352312.
- Q138795 subject Q6427748.
- Q138795 subject Q6547526.
- Q138795 subject Q6582675.
- Q138795 subject Q6993542.
- Q138795 subject Q8266462.
- Q138795 subject Q8505908.
- Q138795 subject Q8883373.
- Q138795 abstract "Stanley Joel Korsmeyer (8 June 1950 – 31 March 2005) was an American oncologist. Through his studies of apoptosis, Korsmeyer helped develop the concepts of the role of programmed cell death in carcinogenesis. In 1989 Korsmeyer was among the first to confirm that a particular form of lymphoma arose in certain B cells because they had a genetic flaw that caused them to overexpress a gene, Bcl-2, that was involved in the body's normal process for getting rid of them. He then conducted a number of studies defining the activity of a number of related genes and their role in apoptosis. Korsmeyer obtained a medical doctorate from the University of Illinois at Chicago, completed a residency at the University of California Hospitals in California, and then trained at the National Cancer Institute under Thomas A. Waldmann and Philip Leder. He then became a tenured professor, first at Washington University and then at Harvard at the Dana-Farber Cancer Institute, working within the Howard Hughes Medical Institute while at both universities. He was widely respected in the field and received numerous prestigious cancer research awards, including the Bristol-Myers Squibb Award for Distinguished Achievement in Cancer Research and the General Motors Cancer Research Foundation Charles S. Mott Prize. He was an elected member of the National Academy of Sciences, the Institute of Medicine, and the American Philosophical Society. The American Society for Clinical Investigation has established a scientific award in his name. In 2000 he was awarded the Louisa Gross Horwitz Prize by Columbia University. He has been credited as the author of nearly 20 articles published since his death from cancer in 2005.".
- Q138795 wikiPageExternalLink horwitz.
- Q138795 wikiPageExternalLink S0092-8674(05)00403-4.
- Q138795 wikiPageWikiLink Q1065982.
- Q138795 wikiPageWikiLink Q1154390.
- Q138795 wikiPageWikiLink Q1159198.
- Q138795 wikiPageWikiLink Q12078.
- Q138795 wikiPageWikiLink Q13371.
- Q138795 wikiPageWikiLink Q14599311.
- Q138795 wikiPageWikiLink Q14863436.
- Q138795 wikiPageWikiLink Q1512226.
- Q138795 wikiPageWikiLink Q162555.
- Q138795 wikiPageWikiLink Q188930.
- Q138795 wikiPageWikiLink Q270794.
- Q138795 wikiPageWikiLink Q30.
- Q138795 wikiPageWikiLink Q415934.
- Q138795 wikiPageWikiLink Q4352382.
- Q138795 wikiPageWikiLink Q466089.
- Q138795 wikiPageWikiLink Q4745011.
- Q138795 wikiPageWikiLink Q49088.
- Q138795 wikiPageWikiLink Q6352312.
- Q138795 wikiPageWikiLink Q6427748.
- Q138795 wikiPageWikiLink Q6547526.
- Q138795 wikiPageWikiLink Q6582675.
- Q138795 wikiPageWikiLink Q664846.
- Q138795 wikiPageWikiLink Q6993542.
- Q138795 wikiPageWikiLink Q777403.
- Q138795 wikiPageWikiLink Q8266462.
- Q138795 wikiPageWikiLink Q8505908.
- Q138795 wikiPageWikiLink Q8883373.
- Q138795 wikiPageWikiLink Q899039.
- Q138795 wikiPageWikiLink Q955764.
- Q138795 type Thing.
- Q138795 comment "Stanley Joel Korsmeyer (8 June 1950 – 31 March 2005) was an American oncologist. Through his studies of apoptosis, Korsmeyer helped develop the concepts of the role of programmed cell death in carcinogenesis. In 1989 Korsmeyer was among the first to confirm that a particular form of lymphoma arose in certain B cells because they had a genetic flaw that caused them to overexpress a gene, Bcl-2, that was involved in the body's normal process for getting rid of them.".
- Q138795 label "Stanley J. Korsmeyer".
- Q138795 homepage horwitz.